APPLE VISION PRO USED IN SUCCESSFUL HIP SURGERY

The FDA's De Novo authorization clears SportSuite Vision as a novel medical device category, enabling surgeons to use Apple Vision Pro during orthopedic procedures. The software provides real-time guidance and visualization during hip surgery, leveraging the headset's spatial computing capabilities. Stryker, a medical technology company, developed the application specifically for surgical environments. De Novo authorization typically applies to devices with no predicate—meaning no substantially similar legally marketed device exists—making this a significant step for mixed reality in operating rooms. The authorization suggests regulatory pathways are opening for AR/VR medical applications. Apple Vision Pro, priced at $3,499, has struggled to find mainstream adoption since its February launch. Medical and surgical use cases represent potential high-value applications for the technology, even as consumer demand remains limited. Stryker's success with FDA approval could prompt other medical device makers to develop Vision Pro applications for specialized surgical procedures.